Sometimes the right hand of the media doesn’t know what the left hand is doing. So, while news side often regurgitates the mantra that ESCR offers the best chance for cures, every once in a while the business side of the media reflects the reality on the ground that adult stem cells are far more advanced. This CNN story is a case in point, in which the following reportage is to be found:
“‘From a Wall Street perspective, adult stem cells are a much better investment,’ said Stephen Dunn of Dawson James Securities. ‘These are the guys who are going to be in the news in 2007 and 2008.’
“President Bush recently vetoed a bill that would loosen federal restrictions on funding for embryonic stem cells, and some analysts fear that as a result the best developments in this area will be made overseas. But work with adult stem cells isn’t being held back by funding restraints and political opposition, analysts say. ‘Embryonic stem cell research hasn’t kept up pace with adult stem cell research,’ said Dunn. ‘Adult stem cell research is advancing so far you might not need embryonic stem cells. If the federal government is reluctant to put their money into it, then Wall Street is as well.’ So while embryonic stem cell researchers are experimenting with rats, adult stem cell researchers have moved on to more advanced tests with humans.”
Once in a while a little light shines through.
Comments are visible to subscribers only. Log in or subscribe to join the conversation.
